Mesoblast corporate update and financial results webcast

New york, nov. 19, 2020 (globe newswire) -- mesoblast limited (nasdaq:meso; asx:msb), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast today to provide a corporate update, and report financial and operational highlights for the first quarter ended september 30, 2020 (fy2021).
MESO Ratings Summary
MESO Quant Ranking